This HTML5 document contains 81 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n11http://dbpedia.org/resource/File:
n15https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n14http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbpedia-zhhttp://zh.dbpedia.org/resource/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Dengvaxia_controversy
rdfs:label
Dengvaxia controversy 登瓦夏爭議
rdfs:comment
登瓦夏爭議（英語：Dengvaxia controversy，Dengvaxia issue或Dengvaxia mess）是关于在菲律宾使用抗登革热疫苗的持续争议。2017年，有几名菲律賓儿童死于因登革热疫苗的各种并发症。此后不久，登革熱疫苗生产商赛诺菲巴斯德发表声明说，在没有登革热感染的人使用疫苗的話會有更高風險，所以疫苗適合登革熱痊愈患者預防使用。2017年11月下旬，暂停了有關学校的赛诺菲巴斯德登革熱疫苗接种计划。 截至2019年8月，已有600多名接种该疫苗的人死亡，其中大部分是儿童（尽管不一定是疫苗本身造成的），而已禁止在该国销售或使用该疫苗。争议引起的恐慌使得该国对疫苗開始失去信心，並且菲律賓國民免疫率也有所降低，最終導致2019年菲律賓麻疹爆發。 The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that the vaccine could put previously uninfected people at a somewhat higher risk of a severe case of dengue fever through antibody-dependent enhancement. A political controversy erupted over whether the program was run with sufficient care and who should be held responsible for the alleged harm to the vaccinated children.
foaf:depiction
n14:President_Aquino_at_the_launching_of_dengue_vaccine_school-based_immunization_in_Region_III.jpg n14:President_Benigno_S._Aquino_III_converses_with_Sanofi_Pasteur_chief_executive_officer_Olivier_Charmeil.jpg
dcterms:subject
dbc:2017_controversies dbc:Health_disasters_in_the_Philippines dbc:Vaccine_controversies dbc:2018_health_disasters dbc:2018_controversies dbc:2017_in_the_Philippines dbc:2018_in_the_Philippines
dbo:wikiPageID
55963248
dbo:wikiPageRevisionID
1115582159
dbo:wikiPageWikiLink
dbr:Department_of_Justice_(Philippines) dbr:President_of_the_Philippines dbr:Francisco_Duque dbc:2017_controversies dbr:Antibody-dependent_enhancement dbr:Dengue_vaccine dbr:Risa_Hontiveros dbr:Ralph_Recto dbr:Juan_Miguel_Zubiri dbr:Edcel_Lagman dbr:Panfilo_Lacson dbr:Dengue_fever n11:President_Aquino_at_the_launching_of_dengue_vaccine_school-based_immunization_in_Region_III.jpg dbr:Senate_of_the_Philippines n11:President_Benigno_S._Aquino_III_converses_with_Sanofi_Pasteur_chief_executive_officer_Olivier_Charmeil.jpg dbc:Vaccine_controversies dbr:Guinea_pig dbr:Calabarzon dbc:Health_disasters_in_the_Philippines dbr:Richard_J._Gordon dbr:Nancy_Binay dbr:Sonny_Angara dbc:2018_health_disasters dbr:Metro_Manila dbr:Sanofi_Pasteur dbc:2018_controversies dbr:Rodrigo_Duterte dbr:JV_Ejercito dbr:Department_of_Health_(Philippines) dbr:Central_Luzon dbr:Win_Gatchalian dbr:Oppression dbr:Department_of_Education_(Philippines) dbr:Grace_Poe dbr:Filipinos dbr:Benigno_Aquino_III dbr:Janette_Garin dbr:Philippines dbr:2019_Philippines_measles_outbreak dbr:Malacañang_Palace dbr:Makati dbc:2018_in_the_Philippines dbr:Tito_Sotto dbr:Gregorio_Honasan dbr:House_of_Representatives_of_the_Philippines dbr:Food_and_Drug_Administration_(Philippines) dbc:2017_in_the_Philippines dbr:2019_measles_outbreak_in_the_Philippines dbr:Manny_Pacquiao
owl:sameAs
dbpedia-zh:登瓦夏爭議 n15:4XGz5 wikidata:Q48802585
dbp:wikiPageUsesTemplate
dbt:Rodrigo_Duterte dbt:Vaccine_safety dbt:IPA-tl dbt:Reflist dbt:Update dbt:More_medical_citations_needed dbt:Short_description dbt:Multiple_issues
dbo:thumbnail
n14:President_Benigno_S._Aquino_III_converses_with_Sanofi_Pasteur_chief_executive_officer_Olivier_Charmeil.jpg?width=300
dbo:abstract
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that the vaccine could put previously uninfected people at a somewhat higher risk of a severe case of dengue fever through antibody-dependent enhancement. A political controversy erupted over whether the program was run with sufficient care and who should be held responsible for the alleged harm to the vaccinated children. In late November 2017, the DOH suspended the school-based vaccination program. The DOH subsequently banned the vaccine's use and sale in the Philippines. The scare caused by the controversy has been suggested as a factor in the country's loss of confidence in vaccines and low immunization rates, resulting in an infectious disease crisis in the country in 2019, including a measles outbreak. 登瓦夏爭議（英語：Dengvaxia controversy，Dengvaxia issue或Dengvaxia mess）是关于在菲律宾使用抗登革热疫苗的持续争议。2017年，有几名菲律賓儿童死于因登革热疫苗的各种并发症。此后不久，登革熱疫苗生产商赛诺菲巴斯德发表声明说，在没有登革热感染的人使用疫苗的話會有更高風險，所以疫苗適合登革熱痊愈患者預防使用。2017年11月下旬，暂停了有關学校的赛诺菲巴斯德登革熱疫苗接种计划。 截至2019年8月，已有600多名接种该疫苗的人死亡，其中大部分是儿童（尽管不一定是疫苗本身造成的），而已禁止在该国销售或使用该疫苗。争议引起的恐慌使得该国对疫苗開始失去信心，並且菲律賓國民免疫率也有所降低，最終導致2019年菲律賓麻疹爆發。
prov:wasDerivedFrom
wikipedia-en:Dengvaxia_controversy?oldid=1115582159&ns=0
dbo:wikiPageLength
27323
foaf:isPrimaryTopicOf
wikipedia-en:Dengvaxia_controversy